ID: h-5744614d14
Hypothesis
HSF1 reprioritizes transcription and suppresses MAPT while restoring proteostasis
Heat-shock signaling either directly or indirectly reduces tau expression as chaperone programs dominate the stress response.
EvidencePending (0%)📖 1 cit🗣 1 debates✓ 6 support✗ 1 oppose
✓ All Quality Gates Passed
🧪 Overview
Heat-shock signaling either directly or indirectly reduces tau expression as chaperone programs dominate the stress response.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["HSF1 Activation<br/>Heat-Shock Transcription Program"]
B["HSP70/HSP90 Chaperone Induction<br/>Proteome Refolding Capacity"]
C["Tau Folding Pressure Reduced<br/>Misprocessing Contained"]
D["Aggregate Clearance Bias<br/>Proteostasis Dominates Stress Response"]
E["Tau Burden Falls<br/>Neuronal Survival Improves"]
A --> B
B --> C
B --> D
C --> E
D --> E
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style E fill:#1b5e20,stroke:#81c784,color:#81c784⚖️ Evidence
⚖️ Evidence Matrix6 supports1 contradicts
Supports
Activation of the heat shock response as a therapeutic strategy for tau toxicity.
Supports
Role of a Heat Shock Transcription Factor and the Major Heat Shock Protein Hsp70 in Memory Formation and Neuroprotection.
Supports
Neuroprotection by Heat Shock Factor-1 (HSF1) and Trimerization-Deficient Mutant Identifies Novel Alterations in Gene Expression.
Supports
M102 activates both NRF2 and HSF1 transcription factor pathways and is neuroprotective in cell and animal models of amyotrophic lateral sclerosis.
Supports
Alcohol protects the CNS by activating HSF1 and inducing the heat shock proteins.
Supports
Heat shock factor 1 promotes neurite outgrowth and suppresses inflammation in the severed spinal cord of geckos.
Contradicts
Reduced MAPT may simply reflect global transcriptional reprioritization rather than direct repression.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — HSF1
No curated PDB or AlphaFold mapping for HSF1 yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for HSF1 from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for HSF1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 0.6%
Volatility
Low
0.0022
Events (7d)
3
Price History
▼8.3%💾 Resource Usage
LLM Tokens
1,548
$0.0046
Total Cost
$0.0046
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF HSF1 is genetically activated via AAV9-mediated CRISPR-dCas9-HSF1 overexpression in the hippocampus of 3xTG-AD mice at 6 months of age, THEN both total tau (Tau5) and phosphorylated tau (AT8) will | ≥40% reduction in hippocampal total tau and phosphorylated tau (AT8) with ≥25% increase in 20S proteasome activity, alongside ≥3-fold elevation of HSPA1A (HSP70 | — no observation — | pending | 0.55 |
| IF HSF1 is pharmacologically activated in N2a neuroblastoma cells or human iPSC-derived neurons with HSF1A (10 μM, 6 hours), THEN MAPT (tau) protein levels will decrease by ≥30% compared to vehicle co | ≥30% reduction in total tau protein (MAPT) with concurrent ≥2-fold increase in HSP70 (HSPA1A) as positive control for HSF1 activation. | — no observation — | pending | 0.65 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF HSF1 is pharmacologically activated in N2a neuroblastoma cells or human iPSC-derived neurons with HSF1A (10 μM, 6 hours), THEN MAPT (tau) protein levels will decrease by ≥30% compared to vehicle control, as measured by quantitative western blot with total tau antibody (Dako A0024), within 48 hour
Predicted outcome: ≥30% reduction in total tau protein (MAPT) with concurrent ≥2-fold increase in HSP70 (HSPA1A) as positive control for HSF1 activation.
Falsification: Tau protein levels remain unchanged (change <10%) or increase despite confirmed HSF1 activation (↑HSP70), indicating HSF1 does not suppress MAPT transcription or translation.
pendingconf 55%
IF HSF1 is genetically activated via AAV9-mediated CRISPR-dCas9-HSF1 overexpression in the hippocampus of 3xTG-AD mice at 6 months of age, THEN both total tau (Tau5) and phosphorylated tau (AT8) will decrease by ≥40% compared to AAV9-GFP control, while proteasome chymotrypsin-like activity will incr
Predicted outcome: ≥40% reduction in hippocampal total tau and phosphorylated tau (AT8) with ≥25% increase in 20S proteasome activity, alongside ≥3-fold elevation of HSP
Falsification: Tau levels remain unchanged or increase despite confirmed HSF1 overexpression and chaperone induction, indicating HSF1 activation is insufficient to suppress MAPT in vivo during neurodegeneration.
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.